Preventing the Progression of Intestinal Failure–Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid - Concepedia

Concepedia

Publication | Closed Access

Preventing the Progression of Intestinal Failure–Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid

149

Citations

34

References

2016

Year

Ivan Diamond, Robert C. Grant, Paul B. Pencharz, Nicole de Silva, Brian M. Feldman, Peter L. Fitzgerald, David L. Sigalet, Bryan J. Dicken, Justine Turner, Valérie Marchand,

Journal of Parenteral and Enteral Nutrition

Abstract

Compared with Intralipid, SMOFlipid reduces the risk of progressive IFALD in children with intestinal failure. This trial was registered at clinicaltrials.gov as NCT00793195.

References

	Year	Citations

Page 1